Victan 2 mg tablets

Victan is a pharmaceutical product containing Ethyl loflazepate, a long-acting benzodiazepine derivative commonly used for the treatment of anxiety disorders. Originally developed in France, the brand has been a staple in the European pharmaceutical market for several decades.

The brand was historically associated with Sanofi, but following a series of strategic acquisitions in the pharmaceutical sector, the rights to Victan in many European markets, including Portugal, were transitioned to Neuraxpharm. Neuraxpharm is a leading European specialty pharmaceutical company focused on Central Nervous System (CNS) disorders. The specific production for the Portuguese market often takes place in national facilities, though components or final packaging may involve a global supply chain within the European Union.